Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting β2 agonists

Thorax

Volumn 56, Issue 7, 2001, Pages 529-535

  Van der Woude, H J ^a   Winter, T H ^a   Aalbers, R ^a  

^a MARTINI HOSPITAL   (Netherlands)

Author keywords

Asthma; Formoterol; Salbutamol; Salmeterol; Tolerance

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FORMOTEROL; IPRATROPIUM BROMIDE; LONG ACTING DRUG; METHACHOLINE; PLACEBO; SALBUTAMOL; SALMETEROL;

ADULT; ARTICLE; BRONCHODILATATION; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG MEGADOSE; DRUG TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LONG TERM CARE; LUNG FUNCTION; MAINTENANCE THERAPY; MALE; PREMEDICATION; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DATA INTERPRETATION, STATISTICAL; DOUBLE-BLIND METHOD; DRUG TOLERANCE; ETHANOLAMINES; FORCED EXPIRATORY VOLUME; HUMANS; METHACHOLINE CHLORIDE; MIDDLE AGED;

EID: 0034949839     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.56.7.529     Document Type: Article

References (31)

1. Standards for the diagnosis and care of patients with COPD and asthma
2. The British guidelines on asthma management. 1995 review and position statement
3. Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction
4. Salmeterol versus formoterol in patients with moderately severe asthma: Onset and duration of action
5. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: Onset of action, duration of effect and potency
6. 2-adrenoceptor agonists with higher efficacy on guinea pig trachea and human bronchus in vivo
7. 2 adrenoceptor agonists: Interactions in human contracted bronchi
8. 2 agonists
9. 2 adrenoreceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients
10. Effect of salmeterol treatment on nitric oxide level in exhaled air and dose-response to terbutaline in children with mild asthma
11. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients
12. 2 adrenoreceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma
13. Systemic corticosteroid rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients
14. Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration
15. Bronchodilator response to salbutamol after chronic dosing with salmeterol or placebo
16. Effect of long term treatment with salmeterol on asthma control: A double blind, randomised crossover study
17. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma
18. Lung function and forced ventilatory flows. Report working party standardisation of lung function tests
19. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients
20. Relative efficacy of three different inhalers containing salbutamol in patients with asthma
21. Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstruction
22. Regular formoterol treatment in mild asthma: Effect on bronchial responsiveness during and after treatment
23. 2 adrenoreceptor agonist, salmeterol, on airway hyyperresponsiveness in patients with mild asthma
24. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol
25. Tolerance to beta-agonists during acute bronchoconstriction
26. Tolerance to beta agonists
27. 2 adrenoreceptor agonists: Time for reappraisal
28. 2 adrenoreceptor agonist/antagonist activity of formoterol and salmeterol
29. 2 responses to fenoterol
30. in vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol